Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Report 2026

Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Overview

• Quantitative Polymerase Chain Reaction (qPCR) Instruments market size has reached to $1.66 billion in 2025 • Expected to grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Rising Infectious Disease Burden Fuels Demand For The Market Growth Due To Early And Accurate Pathogen Detection Needs • Market Trend: Innovative qPCR Technologies Drive Growth Amid Rising Demand For Molecular Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Quantitative Polymerase Chain Reaction (qPCR) Instruments Market?

Quantitative polymerase chain reaction (qPCR) instruments are specialized laboratory devices used to amplify and simultaneously quantify targeted DNA sequences in real-time. These instruments monitor the accumulation of DNA during each cycle of amplification through fluorescent signals, allowing researchers to measure the amount of DNA with high sensitivity and accuracy. These instruments are essential tools in molecular biology, diagnostics, and research for applications such as gene expression analysis, pathogen detection, and genetic variation studies. The main product types of quantitative polymerase chain reaction (qPCR) instruments are quantitative polymerase chain reaction systems, reagents and consumables, and software. Quantitative polymerase chain reaction systems refer to laboratory instruments designed to amplify and quantify DNA or RNA sequences in real time using fluorescence-based detection. The various systems include the 7500, ViiA 7 Dx, Cobas 4800, CFX96, smartcycler, genexpert, rotor-gene Q, rotor-gene Q 5plex HRM System, biofire filmarray systems, and others. These instruments are used in various applications such as gene expression analysis, genotyping, pathogen detection, diagnostics, and others and are utilized by end-users including diagnostic laboratories, hospitals and clinics, pharmaceutical and biotechnology companies, and others.

What Is The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Growth Forecast?

The quantitative polymerase chain reaction (qpcr) instruments market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing adoption of point-of-care diagnostics, expansion of molecular testing in emerging markets, integration of ai and cloud-based analytics, demand for rapid pathogen detection, rising government funding for genomics research. Major trends in the forecast period include high-throughput testing adoption, integration of automation in qpcr workflows, miniaturization of qpcr instruments, demand for multiplexing capabilities, development of point-of-care qpcr solutions.

Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Segmentation

1) By Product Type: Quantitative Polymerase Chain Reaction Systems, Reagents And Consumables, Software 2) By Instrument: 7500, Viia 7 Dx, Cobas 4800, Cfx96, Smartcycler, Genexpert, Rotor-Gene Q, Rotor-Gene Q 5plex Hrm System, Biofire Filmarray Systems, Other Instruments 3) By Application: Gene Expression, Genotyping, Pathogen Detection, Diagnostics, Other Applications 4) By End-Users: Diagnostic Laboratories, Hospitals And Clinics, Pharma And Biotech Companies, Other End-Users Subsegments: 1) By Quantitative Polymerase Chain Reaction (qPCR) Systems: Real-Time Polymerase Chain Reaction Systems, Portable Or Compact qPCR Devices, Digital Polymerase Chain Reaction Systems 2) By Reagents And Consumables: Master Mixes, Buffers And Enzymes, Primers 3) By Software: Data Analysis Software, Cloud-Based Analytics Platforms, Instrument Control Software

What Is The Driver Of The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market?

The increasing incidence of infectious diseases is expected to propel the growth of the quantitative polymerase chain reaction (qPCR) instruments market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals. Infectious diseases are increasing due to the rise in global travel, which facilitates the rapid spread of pathogens across borders. Quantitative polymerase chain reaction (qPCR) instruments help combat infectious diseases by enabling rapid, sensitive, and precise detection of pathogens, allowing for timely diagnosis and effective disease management. For instance, in February 2024, according to GOV.UK, a UK-based government department, the number of tuberculosis (TB) cases in England increased from 4,380 in 2022 to 4,850 in 2023. Therefore, the increasing incidence of infectious diseases is driving the growth of the quantitative polymerase chain reaction (qPCR) instruments industry.

Key Players In The Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market

Major companies operating in the quantitative polymerase chain reaction (qpcr) instruments market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc, Bio Rad Laboratories Inc, QIAGEN N V, Eppendorf SE, Cepheid Inc, Takara Bio Inc, bioMerieux SA, Analytik Jena GmbH, Standard BioTools Inc, Hangzhou Bioer Technology Co Ltd, BioTeke Corporation, GeneReach Biotechnology Corp, Anitoa Systems LLC, Blue Ray Biotech Corp, Chai Biotechnologies, Bio Molecular Systems Pty Ltd, Azure Biosystems Inc

Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Trends and Insights

Major companies operating in the Quantitative Polymerase Chain Reaction (qPCR) Instruments market are focusing on developing innovative solutions, such as next-generation real-time qPCR systems that combine clinical-grade workflows with research flexibility, to meet the rising demand for faster, higher-throughput molecular diagnostics, improved assay sensitivity for personalized medicine and oncology, and greater outbreak-readiness for infectious disease testing. A next-generation qPCR system is a real-time PCR instrument that retains the core principle of qPCR (simultaneous amplification and fluorescent detection of nucleic acids) but adds features such as enhanced thermal uniformity, advanced signal-processing algorithms, ergonomic user interfaces, regulatory-ready IVD workflows. For instance, in November 2023, Roche Holding AG, a Switzerland-based diagnostics and biotechnology company, launched the LightCycler PRO System, an innovative next-generation qPCR platform. The LightCycler PRO System is built on Roche’s LightCycler heritage and is designed for both research and IVD use, it features a new vapour chamber to improve temperature uniformity across the block, updated software and user interface with improved algorithms for signal analysis, and the flexibility to run user-developed assays alongside a large catalogue of validated LightMix research and CE-IVD assays.

What Are Latest Mergers And Acquisitions In The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market?

In April 2023, Thermo Fisher Scientific Inc., a US-based life science and clinical research company, partnered with ALPCO-GeneProof to expand access to PCR diagnostic solutions. With this partnership, Thermo Fisher aims to enhance its molecular diagnostics offerings by expanding its CE-IVD assay portfolio and strengthening its presence in the European clinical testing market. ALPCO-GeneProof is a US-based diagnostics company offering solutions in both molecular and immunodiagnostics.

Regional Outlook

North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Quantitative Polymerase Chain Reaction (qPCR) Instruments Market?

The quantitative polymerase chain reaction (qPCR) instrument market consists of revenues earned by entities providing services such as analysis software, installation and training, technical support, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantitative polymerase chain reaction (qPCR) instrument market also includes sales of thermal cyclers, optical detection systems, reaction tubes and plates, and analysis software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.